What kind of ester could allow an injection to last for 3 months?
Nebido® is the first 3-monthly injectable testosterone preparation for the treatment of testosterone deficiency.
Nebido® reliably alleviates symptoms and prevents consequences of testosterone deficiency such as decreased sexual desire, decreased muscle mass and strength, fatigue, depressive mood as well as a lacking of, incomplete development, or regression of secondary sexual characteristics, and an increased risk of osteoporosis.
Patients value the consistent, reliable efficacy and the long duration of effect. Nebido® liberates patients from the burden of approximately 20 injections of conventional testosterone therapy per year. In contrast, only four injections of Nebido® are required per year.
Nebido® will be introduced in Europe, starting in Finland and Germany, autumn 2004. Other European countries will follow in 2005. Launches in Latin American and Asian will start 2005.
Reply With Quote